Tepnel starts Construction of new state-of-the-art Scottish Laboratories
The new facility is planned to come on stream in the second quarter of 2007 and will initially employ 42 people who are currently located at Tepnel's two existing Scottish facilities in Glasgow and Edinburgh. The new facility will serve as an outsourcing resource to the fast growing biological medicines sector.
The project is being part funded by Scottish Enterprise Edinburgh and Lothian. Scottish Enterprise CEO Jack Perry commented: "It is gratifying to see a UK-based company in a key industry for Scotland investing in the future by creating and expanding its business and adding jobs to the economy. This new facility will contribute to Scotland's economy and more specifically will open the door to the biopharmaceutical marketplace which is currently valued at £24 billion and has been growing at an impressive rate over the last five years."
Topics
Organizations
Other news from the department manufacturing
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Protein analytics
Protein analytics provides a deep insight into these complex macromolecules, their structure, function and interactions. It is essential for discovering and developing biopharmaceuticals, understanding disease mechanisms, and identifying therapeutic targets. Techniques such as mass spectrometry, Western blot and immunoassays allow researchers to characterize proteins at the molecular level, determine their concentration and identify possible modifications.
Topic world Protein analytics
Protein analytics provides a deep insight into these complex macromolecules, their structure, function and interactions. It is essential for discovering and developing biopharmaceuticals, understanding disease mechanisms, and identifying therapeutic targets. Techniques such as mass spectrometry, Western blot and immunoassays allow researchers to characterize proteins at the molecular level, determine their concentration and identify possible modifications.